Equities

Benchmark Holdings PLC

BMK:LSE

Benchmark Holdings PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)44.75
  • Today's Change-3.25 / -6.77%
  • Shares traded143.49k
  • 1 Year change4.07%
  • Beta0.9630
Data delayed at least 20 minutes, as of Apr 26 2024 16:36 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Benchmark Holdings PLC grew revenues 7.46% from 157.71m to 169.48m while net income improved from a loss of 32.09m to a smaller loss of 23.15m.
Gross margin52.03%
Net profit margin-14.80%
Operating margin-6.15%
Return on assets-4.93%
Return on equity-8.47%
Return on investment-5.81%
More ▼

Cash flow in GBPView more

In 2023, Benchmark Holdings PLC did not generate a significant amount of cash. However, the company earned 20.01m from its operations for a Cash Flow Margin of 11.80%. In addition the company used 5.27m on investing activities and also paid 12.33m in financing cash flows.
Cash flow per share0.0195
Price/Cash flow per share23.14
Book value per share0.3529
Tangible book value per share0.0892
More ▼

Balance sheet in GBPView more

Benchmark Holdings PLC has a Debt to Total Capital ratio of 26.99%, a lower figure than the previous year's 28.78%.
Current ratio2.07
Quick ratio1.67
Total debt/total equity0.3783
Total debt/total capital0.2699
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.